S. Baron

发表

Transcatheter Aortic Valve Replacement Versus Surgical Aortic Valve Replacement: How Would You Manage This Patient With Severe Aortic Stenosis?

E. Reynolds, H. Libman, T. Kaneko, 2021, Annals of Internal Medicine.

SCAI Expert Consensus Statement on Sex-Specific Considerations in Myocardial Revascularization

C. Grines, A. Jacobs, J. Saw, 2022, Journal of the Society for Cardiovascular Angiography & Interventions.

Cost-Effectiveness of Transcatheter Aortic Valve Replacement With a Self-Expanding Prosthesis Versus Surgical Aortic Valve Replacement.

D. Adams, C. Meduri, J. Popma, 2016, Journal of the American College of Cardiology.

Prediction of Poor Outcome After Transcatheter Aortic Valve Replacement.

D. Adams, J. Spertus, J. Afilalo, 2016, Journal of the American College of Cardiology.

Dual Mechanisms Regulating AMPK Kinase Action in the Ischemic Heart

L. Witters, T. Wallimann, D. Neumann, 2005, Circulation research.

Long-term experience and outcomes with transcatheter closure of patent foramen ovale.

F. Buonanno, I. Palacios, J. Hung, 2013, JACC. Cardiovascular interventions.

Anticoagulation with the direct thrombin inhibitor argatroban in patients presenting with acute coronary syndromes

R. Yeh, I. Cruz-González, I. Jang, 2009, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Caesarian dissection: a case of chest pain and dyspnea during delivery.

R. Yeh, S. Baron, N. Scott, 2013, Circulation.

Outcomes of COVID-19 in Patients With a History of Cancer and Comorbid Cardiovascular Disease.

D. Kazi, F. Resnic, K. Rieger-Christ, 2020, Journal of the National Comprehensive Cancer Network : JNCCN.

Efficacy and safety of argatroban in patients with heparin induced thrombocytopenia undergoing endovascular intervention for peripheral arterial disease

R. Yeh, I. Cruz-González, K. Rosenfield, 2008, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Retrograde-Antegrade Snaring With Electrosurgery and Removal of a Ruptured Papillary Muscle

T. Piemonte, M. Bode, S. Baron, 2020, Circulation. Cardiovascular interventions.

The Challenges of Success: Maintaining Access to High Quality PCI in the Face of Declining Procedural Volumes

R. Yeh, D. Cohen, S. Baron, 2014 .

J. Abbott, Ayman Elbadawi, Mohamed A. Omer, 2022, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Argatroban therapy in women with heparin-induced thrombocytopenia.

I. Jang, E. Anglade, S. Baron, 2007, Journal of women's health.

What is the optimal anticoagulation level with argatroban during percutaneous coronary intervention?

R. Yeh, I. Cruz-González, I. Jang, 2008, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Dual Mechanisms Regulating AMP-Activated Protein Kinase Action in the Ischemic Heart

L. Witters, D. Neumann, E. Miller, 2005 .

Activation of 5'amp-activated protein kinase kinase in the ischemic myocardium

S. Baron, 2005 .

The use of MitraClip to prevent posttranscatheter aortic valve replacement left ventricular “suicide”

M. Bode, S. Baron, Gautam Gadey, 2020, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Socioeconomic and Geographic Characteristics of Hospitals Establishing Transcatheter Aortic Valve Replacement Programs, 2012–2018

J. Bavaria, J. Giri, N. Desai, 2021, Circulation. Cardiovascular Quality and Outcomes.

The Evolving Role of the Multidisciplinary Heart Team in Aortic Stenosis

T. Kaneko, S. Baron, Sahoor Khan, 2022, US Cardiology Review.

Impact of Short-Term Complications on Mortality and Quality of Life after TAVR

M. Mack, M. Leon, D. C. Miller, 2019 .

Economic Implications of Transcatheter Aortic Valve Replacement in Patients at Intermediate Surgical Risk.

D. Cohen, M. Reynolds, S. Baron, 2016, Circulation.

Bioprosthetic Valve Fracture Improves the Hemodynamic Results of Valve-in-Valve Transcatheter Aortic Valve Replacement

D. Dvir, D. Cohen, K. Allen, 2017, Circulation. Cardiovascular interventions.

Evaluating the Cost-Effectiveness of Transcatheter Mitral Valve Therapies for the Treatment of Mitral Regurgitation: “To Infinity and Beyond”

S. Baron, 2020 .

Clinical Trial Perspective: Cost-effectiveness of Transcatheter Mitral Valve Repair Versus Medical Therapy in Patients with Heart Failure and Secondary Mitral Regurgitation. Results From the COAPT Trial

S. Baron, 2020 .

Health Status after Transcatheter Mitral Valve Repair in Patients with Heart Failure and Secondary Mitral Regurgitation: COAPT Trial

J. Spertus, G. Stone, W. Abraham, 2019 .

Outcomes of stroke events during transcatheter aortic valve implantation.

D. Kazi, R. Yeh, J. Strom, 2022, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Quality of Life after Everolimus-Eluting Stents or Bypass Surgery for Treatment of Left Main Disease after

P. Serruys, G. Stone, D. Kandzari, 2017 .

Days at Home After Transcatheter vs Surgical Aortic Valve Replacement in Intermediate-Risk Patients.

D. Kazi, R. Yeh, Yang Song, 2021, JAMA cardiology.

COCATS 4: Securing the Future of Cardiovascular Medicine.

S. Sinha, Stephanie L. Siehr, S. Krim, 2015, Journal of the American College of Cardiology.

Point: patients with native aortic regurgitation can be treated with transcatheter aortic valve implantation

S. Baron, Sahoor Khan, 2021, Heart.

Hospital Resource Utilization Before and After Transcatheter Aortic Valve Replacement: The STS/ACC TVT Registry.

M. Mack, B. Hammill, D. Holmes, 2019, Journal of the American College of Cardiology.

Bioprosthetic Valve Fracture to Facilitate Transcatheter Valve-in-Valve Implantation.

D. Dvir, D. Cohen, K. Allen, 2017, The Annals of thoracic surgery.

Days at Home after Transcatheter or Surgical Aortic Valve Replacement in High-Risk Patients.

Neel M. Butala, D. Kazi, R. Yeh, 2022, American heart journal.

Clinical Research on Transcatheter Aortic Valve Replacement for Bicuspid Aortic Valve Disease: Principles, Challenges, and an Agenda for the Future

J. Leipsic, M. Leon, M. Borger, 2022, Structural heart : the journal of the Heart Team.

Impact of Social Vulnerability on Comorbid Cancer and Cardiovascular Disease Mortality in the United States

D. Kazi, K. Nasir, Jennifer E Liu, 2022, JACC. CardioOncology.

Prosthetic valve endocarditis: Literally a growing concern following transcatheter aortic valve replacement

A. Goldsweig, S. Baron, 2022, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Efficacy and safety of argatroban with or without glycoprotein IIb/IIIa inhibitor in patients with heparin induced thrombocytopenia undergoing percutaneous coronary intervention for acute coronary syndrome

R. Yeh, I. Cruz-González, I. Jang, 2008, Journal of Thrombosis and Thrombolysis.

Quality-of-Life Assessment in the EXCEL Trial.

G. Stone, D. Cohen, S. Baron, 2018, JACC. Cardiovascular interventions.

Cerebral Embolic Protection During Transcatheter Aortic Valve Replacement Significantly Reduces Death and Stroke Compared With Unprotected Procedures.

W. Rottbauer, S. Messé, I. Meredith, 2017, JACC. Cardiovascular interventions.

Lange pathology flash cards

Christoph I. Lee, S. Baron, 2013 .

AMP-activated protein kinase: a key stress signaling pathway in the heart.

R. Russell, Ji Li, L. Young, 2005, Trends in cardiovascular medicine.

Chapter 11 – Advances in Coronary Revascularization

S. Mick, P. Shekar, S. Baron, 2013 .

Quality-of-Life After Everolimus-Eluting Stents or Bypass Surgery for Left-Main Disease: Results From the EXCEL Trial.

P. Serruys, G. Stone, D. Kandzari, 2017, Journal of the American College of Cardiology.

Quality of Life after Everolimus-Eluting Stents or Bypass Surgery for Treatment of Left Main Disease

P. Serruys, G. Stone, D. Kandzari, 2017 .

Economic Outcomes of Bioresorbable Vascular Scaffolds Versus Everolimus-Eluting Stents in Patients Undergoing Percutaneous Coronary Intervention: 1-Year Results From the ABSORB III Trial.

G. Stone, S. Ellis, D. Cohen, 2017, JACC. Cardiovascular interventions.

Effectiveness and safety of percutaneous coronary intervention after fibrinolytic therapy for ST-segment elevation acute myocardial infarction.

R. Giugliano, S. Baron, 2011, The American journal of cardiology.

Health Status After Transcatheter Mitral-Valve Repair in Heart Failure and Secondary Mitral Regurgitation: COAPT Trial.

M. Mack, J. Spertus, G. Stone, 2019, Journal of the American College of Cardiology.

Impact of Ejection Fraction and Aortic Valve Gradient on Outcomes of Transcatheter Aortic Valve Replacement.

Sean M. O'Brien, D. Holmes, H. Herrmann, 2016, Journal of the American College of Cardiology.

Contemporary Costs Associated With Transcatheter Versus Surgical Aortic Valve Replacement in Medicare Beneficiaries

C. Gunnarsson, S. Baron, M. Ryan, 2022, Circulation. Cardiovascular interventions.

Cost-Effectiveness of Transcatheter Mitral Valve Repair versus Medical Therapy in Patients with Heart Failure and Secondary Mitral Regurgitation: Results from the COAPT Trial.

M. Mack, G. Stone, B. Whisenant, 2019, Circulation.

Cost-Effectiveness of Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Intermediate Risk: Results From the PARTNER 2 Trial

M. Mack, L. Svensson, M. Leon, 2019, Circulation.

The challenges of success: maintaining access to high-quality percutaneous coronary intervention in the face of declining procedural volumes.

R. Yeh, D. Cohen, S. Baron, 2014, Circulation.

Association of Smoking Status With Long‐Term Mortality and Health Status After Transcatheter Aortic Valve Replacement: Insights From the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry

J. Spertus, A. Kosinski, S. Arnold, 2019, Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease.

Association of Transcatheter Mitral Valve Repair With Quality of Life Outcomes at 30 Days and 1 Year: Analysis of the Transcatheter Valve Therapy Registry

M. Mack, J. Rumsfeld, A. Kosinski, 2018, JAMA cardiology.

Predicting Quality of Life at 1 Year After Transcatheter Aortic Valve Replacement in a Real-World Population

F. Edwards, S. Arnold, D. Cohen, 2018, Circulation. Cardiovascular quality and outcomes.

Transcatheter Versus Surgical Aortic Valve Replacement: Propensity-Matched Comparison.

Sean M. O'Brien, M. Pencina, M. Mack, 2017, Journal of the American College of Cardiology.

Quality-of-Life Outcomes After Transcatheter Aortic Valve Replacement in an Unselected Population: A Report From the STS/ACC Transcatheter Valve Therapy Registry

M. Mack, J. Spertus, J. Rumsfeld, 2017, JAMA cardiology.

Association of Patient-Reported Health Status With Long-Term Mortality After Transcatheter Aortic Valve Replacement: Report From the STS/ACC TVT Registry

Sean M. O'Brien, M. Mack, J. Spertus, 2015, Circulation. Cardiovascular interventions.

Sex Differences in Outcomes Following Left Atrial Appendage Closure.

D. Holmes, J. Abbott, M. Mamas, 2021, Mayo Clinic proceedings.

Hot topics in interventional cardiology: Proceedings from the society for cardiovascular angiography and interventions (SCAI) 2021 think tank

Peter L Duffy, D. Gutfinger, J. Messenger, 2021, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Real-world Efficacy of Tafamidis in Patients with Transthyretin Amyloidosis and Heart Failure.

Kathleen W. Zhang, D. Lenihan, Joshua D. Mitchell, 2023, Current problems in cardiology.

Cost-Effectiveness of Tafamidis Therapy for Transthyretin Amyloid Cardiomyopathy

Sanjiv J. Shah, J. Spertus, M. Maurer, 2020, Circulation.

Editorial: Extending the Minimalist Approach to the Pre-Transcatheter Aortic Valve Replacement Coronary Evaluation

Natalia C. Berry, S. Baron, 2022, Structural heart : the journal of the Heart Team.

Racial, Ethnic, and Socioeconomic Disparities in Access to Transcatheter Aortic Valve Replacement Within Major Metropolitan Areas.

N. Desai, B. Nallamothu, H. Herrmann, 2021, JAMA cardiology.

Utilization trends in Platelet adenosine diphosphate P2Y12 Receptor Inhibitor and cost among Medicare Beneficiaries.

F. Resnic, S. Baron, S. Ganatra, 2023, Current problems in cardiology.

Stroke After Surgical Versus Transfemoral Transcatheter Aortic Valve Replacement in the PARTNER Trial.

M. Mack, E. Tuzcu, L. Svensson, 2018, Journal of the American College of Cardiology.

Health Status Benefits of Transcatheter vs Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Intermediate Surgical Risk: Results From the PARTNER 2 Randomized Clinical Trial

M. Mack, L. Svensson, M. Leon, 2017, JAMA cardiology.

Cerebral Embolic Protection during Transcatheter Aortic-Valve Replacement.

W. Rottbauer, S. Messé, I. Meredith, 2022, The New England journal of medicine.

Exploring the Reduction in Hospitalization Costs Associated with Next-Day Discharge following Transfemoral Transcatheter Aortic Valve Replacement in the United States

D. Wood, S. Lauck, J. Webb, 2019, Structural Heart.

In-Hospital Costs and Costs of Complications of Chronic Total Occlusion Angioplasty: Insights From the OPEN-CTO Registry.

J. Spertus, J. Moses, S. Arnold, 2019, JACC. Cardiovascular interventions.

Temporal Changes in Mortality After Transcatheter and Surgical Aortic Valve Replacement: Retrospective Analysis of US Medicare Patients (2012–2019)

D. Wood, S. Lauck, J. Webb, 2021, Journal of the American Heart Association.

Impact of Short-Term Complications on Mortality and Quality of Life After Transcatheter Aortic Valve Replacement.

M. Mack, M. Leon, D. C. Miller, 2019, JACC. Cardiovascular interventions.

Durability of quality of life benefits of transcatheter aortic valve replacement: Long‐term results from the CoreValve US extreme risk trial

D. Adams, J. Popma, S. Arnold, 2017, American heart journal.

Percutaneous Coronary Intervention: Finally Mature Enough.

D. Cohen, S. Rinfret, S. Baron, 2015, Journal of the American College of Cardiology.

Effect of SAPIEN 3 Transcatheter Valve Implantation on Health Status in Patients With Severe Aortic Stenosis at Intermediate Surgical Risk: Results From the PARTNER S3i Trial.

E. Tuzcu, M. Leon, D. C. Miller, 2018, JACC. Cardiovascular interventions.

Health Status after Transcatheter vs. Surgical Aortic Valve Replacement in Low-Risk Patients with Aortic Stenosis.

M. Mack, M. Leon, S. Kapadia, 2019, Journal of the American College of Cardiology.

Health Status After Transcatheter or Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Increased Surgical Risk: Results From the CoreValve US Pivotal Trial.

D. Adams, J. Popma, S. Arnold, 2015, JACC. Cardiovascular interventions.

Very early changes in quality of life after transcatheter aortic valve replacement: Results from the 3M TAVR trial.

D. Wood, S. Lauck, J. Webb, 2020, Cardiovascular revascularization medicine : including molecular interventions.

Cerebral Embolic Protection in Transcatheter Aortic Valve Replacement

W. Rottbauer, S. Messé, A. Lansky, 2023, Structural heart : the journal of the Heart Team.

Reading the Digital Tea Leaves: Hope or Hype for Peripheral Artery Disease.

M. Bunte, S. Baron, 2020, Circulation. Cardiovascular Interventions.

Cerebral Embolic Protection during Transcatheter Aortic-Valve Replacement.

W. Rottbauer, S. Messé, I. Meredith, 2022, The New England journal of medicine.

Impact of SGLT2 Inhibitors on Atrial Fibrillation Recurrence After Catheter Ablation in Patients With Type-2-Diabetes.

M. Reynolds, M. Kosiborod, T. Neilan, 2023, JACC. Clinical electrophysiology.

SCAI Position Statement on Best Practices for Percutaneous Axillary Arterial Access and Training

J. Messenger, D. Schneider, D. Baran, 2022, Journal of the Society for Cardiovascular Angiography & Interventions.

Prediction of Poor Outcome After Transcatheter Aortic Valve Replacement.

D. Adams, J. Spertus, J. Afilalo, 2016, Journal of the American College of Cardiology.

Sex Differences in pLVAD-Assisted High-Risk Percutaneous Coronary Intervention: Insights From the PROTECT III Study.

W. O’Neill, C. Grines, A. Lansky, 2023, JACC: Cardiovascular Interventions.

T. Henry, S. Baron, A. Jacobs, 2023, Journal of the American College of Cardiology.

Percutaneous Coronary Intervention: Finally Mature Enough.

S. Rinfret, S. Baron, D. Cohen, 2015, Journal of the American College of Cardiology.

Tricuspid Valve Academic Research Consortium Definitions for Tricuspid Regurgitation and Trial Endpoints.

J. Leipsic, G. Ailawadi, B. Redfors, 2023, Journal of the American College of Cardiology.